Low-Dose Acetylsalicylic Acid Treatment in Non-Skull-Base Meningiomas: Impact on Tumor Proliferation and Seizure Burden.

Cancers (Basel) · 2022 · PMC9454729 · PMID 36077817

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, the results from national registries in Denmark showed a trend that the long-term use (≥5 years) of low-dose ASA slightly reduces the overall risk of glioma compared to patients receiving the medication for less than 5 years [ 52 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.